Journal of Regenerative Science

 

  1. About the Journal

Journal of Regenerative Science is open access, Double-blind peer-reviewed as a Semi annual journal with contributions from all across the globe started in the December 2021. Publishing articles related to Regenerative Sciences focusing on stem cell biology, tissue engineering, and regenerative medicine. ISSN online is 2583-651X

 

  1. Aims & Scope of the journal

Journal of Regenerative Science (JRS) publishes original and interesting case reports that contribute significantly to Regenerative. The focus of the journal will be clinical, medical and surgical Regenerative Therapy is a multidisciplinary journal that publishes original articles and reviews of basic research, clinical translation, industrial development, and regulatory issues focusing on stem cell biology, tissue engineering, and regenerative medicine. This journal primarily aims to cater to clinicians, researchers and health-care providers whose focus is on the understanding and treatment of Journal of Regenerative Science.

 

  1. Open Access Publication and Creative Commons Licensing

This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

 

  1. Editorial Process

A manuscript will be reviewed for possible publication with the understanding that it is being submitted to JRS alone at that point of time and it has not been published anywhere or simultaneously submitted/accepted for publication elsewhere. One of the authors should be authorized to correspond with the Journal for all matters related to the manuscript.

All manuscripts submitted are duly acknowledged. The submitted manuscripts are first checked for plagiarism using Google and then reviewed for suitability for publication in JRS. Manuscripts with high plagiarism, insufficient originality, major scientific or technical flaws and/or lack of a significant message are rejected at this stage along with manuscripts that are unlikely to be of interest to JRS readers. Suitable manuscripts are then subjected to a comprehensive review by the Editorial Team and/or an internal reviewer to check their adherence to reporting guidelines and robustness in rationale and methodology. If deemed necessary, manuscripts may be sent back to authors for making amendments. In such cases, only manuscripts in which satisfactory changes are made would be considered for further stages.

Manuscripts are then sent to a minimum of two independent expert reviewers to assess the scientific quality of the manuscript. The Journal follows a double-blind peer review process. The Editor-in-Chief, based on the comments and recommendations of reviewers, takes a final decision on the manuscript. The comments and suggestions (i.e., acceptance/rejection/revision) received from reviewers are conveyed to the corresponding author. If a manuscript requires revision, the author(s) is requested to provide a point-by-point response to reviewers’ comments and submit a revised version of the manuscript. This process is repeated until reviewers and editors are satisfied with the response.

Editorial Board Members are also excluded from all publication processes and decisions of manuscripts in which they are authors or may have actual or potential competing interest.

Manuscripts accepted for publication undergo substantial editing, as required, in addition to copyediting for grammar, punctuation, print style and format. All proofs are sent to the corresponding author. The corresponding author is expected to return the corrected proofs within the recommended timeframe. It may not be possible to incorporate corrections received after that period. The entire process from submission of the manuscript to final decision and the subsequent sending and receiving proofs is completed online through the website

To achieve faster and greater dissemination of knowledge and information, the Journal publishes articles online as ‘Ahead of Print’.

  1. Policy against Plagiarism

The Journal follows strict anti-plagiarism policy and defines plagiarism as duplicate publication of the author’s own work, in whole or in part without proper citation, or mispresenting other’s ideas, words, and other creative expression as one’s own. All manuscripts submitted to JRS undergo plagiarism check with the Google. Only in cases of minor duplication or similarity with previous published work, the authors may be provided an opportunity to rectify the same; in all other cases, the manuscript is desk rejected along with the plagiarism report (please also see the Scientific Misconduct section for additional details).

 

  1. Clinical Trial Registry

 

JRS prefers clinical trials to be registered with a clinical trial registry that allows unhindered and free online access to public. Some of the accepted trial registers are as follows: https://www.clinicaltrials.gov/; http://ctri.nic.in/Clinicaltrials/login.php;  http://www.trialregister.nl/trialreg/index.asp. This is applicable to clinical trials that have begun enrolment of subjects in or after June 2008. From January 2021, the Journal would only consider submissions of clinical trials that have been registered, including those that commenced enrolment of subjects prior to June 2008 but retrospectively registered with a clinical trial registry that meets the Journal’s preference.

 

  1. Authorship Criteria

Authorship credit should be based only on substantial contributions to each of the three components mentioned below:

 

  1. Concept and design of study or acquisition of data or analysis and interpretation of data;
  2. Drafting the article or revising it critically for important intellectual content; and
  3. Final approval of the version to be published. Participation solely in the acquisition of funding or the collection of data does not justify authorship. General supervision of the research group is not sufficient for authorship. Each contributor should have participated sufficiently in the work to take public responsibility for appropriate portions of the content of the manuscript. The order of naming the contributors should be based on the relative contribution of the contributor towards the study and writing the manuscript. Once submitted the order cannot be changed without written consent of all the contributors.

 

Please note that although the Journal does not specify a maximum number of authors, if requested, the authors should provide a justification if the number of authors exceed 6 for original articles, 4 for case reports and short communications/brief reports and 2 for letters to editor.

 

  1. Contribution Details

Contributors should provide a description of contributions made by each of them towards the manuscript. Description should be divided in following categories, as applicable: concept, design, definition of intellectual content, literature search, clinical studies, experimental studies, data acquisition, data analysis, statistical analysis, manuscript preparation, manuscript editing and manuscript review. One or more author should take responsibility for the integrity of the work from inception to publication and should be designated as the ‘guarantor’.

 

  1. Conflicts of Interest/ Competing Interests: Link

All authors of articles must disclose any and all conflicts of interest they may have with publication of the manuscript or an institution or product that is mentioned in the manuscript and/or is important to the outcome of the study presented. Authors should also disclose conflict of interest with products that compete with those mentioned in their manuscript. If the articles are authored by the editorial board, the conflict of interest must be clearly stated.

 

  1. Submission of Manuscripts

All manuscripts must be submitted online through the website link.  First-time users would have to register at this site. Registration is free but mandatory. Registered authors can keep track of their articles after logging into the site using their username and password. Authors do not have to pay for submission. The processing or publishing articles will be 3500 INR or 150 $ (for international articles). The publishing charges have to be paid only on acceptance of the article. If you experience any problems, please contact the Editorial office by e-mail at: jrs@gmail.com

Submitted manuscripts that are not as per the “Instructions to Authors” would be returned to the authors for technical correction, before they undergo editorial/ peer-review. Generally, the manuscript should be submitted in the form of two separate files:

 

[1] Title Page/First Page File/covering letter:

 

This file should provide the following:

 

  1. a) The type of manuscript, title of the manuscript (not more than 15 words), running title (not more than 55 characters, including spaces), names of all authors/contributors (with their highest academic degrees, designation and affiliations) and name(s) of department(s) and/ or institution(s) to which the work should be credited. All information which can reveal your identity should be here. Use text/rtf/doc files. Do not zip the files.

 

  1. b) The total number of pages, total number of photographs and separate word counts for the abstract and text (excluding the references, tables and abstract).

 

  1. c) A statement confirming appropriate patient consent has been obtained. For Case Reports, please see the Case Report section for further details and appropriate forms.

 

  1. d) Source(s) of support in the form of grants, equipment and/or drugs.

 

  1. e) Acknowledgement, if any. One or more statements should specify 1) contributions that need acknowledging but do not justify authorship, such as general support by a departmental chair; 2) acknowledgments of technical help; and 3) acknowledgments of financial and material support, which should specify the nature of the support.

 

  1. f) If the manuscript was presented as part at a meeting, the organization, place and exact date on which it was read. A full statement to the editor about all submissions and previous reports that might be regarded as redundant publication of the same or very similar work. Any such work should be referred to specifically and referenced in the new paper. Copies of such material should be included with the submitted paper, to help the editor decide how to proceed with the manuscript.
  2. g)    Registration number in case of a clinical trial and where it is registered (name of the registry and its URL).
  3. h)    Conflicts of Interest of each author/ contributor. A statement of financial or other relationships that might lead to a conflict of interest, if that information is not included in the manuscript itself or in an authors’ form.
  4. i)     Criteria for inclusion in the authors’/ contributors’ list.
  5. j)     A statement that the manuscript has been read and approved by all the authors, that the requirements for authorship as stated earlier in this document have been met and that each author believes that the manuscript represents honest work, if that information is not provided in another form (see below); and
  6. k)    The name, address, e-mail and telephone number of the corresponding author, who is responsible for communicating with the other authors about revisions and final approval of the proofs, if that information is not included on the manuscript itself.

 

[2] Blinded Article file: The manuscript must not contain any mention of the authors’ names or initials or the institution at which the study was done or acknowledgements. Page headers/running title can include the title but not the authors’ names. Manuscripts not in compliance with The Journal’s blinding policy will be returned to the corresponding author. The main text of the article, i.e., from Abstract to References (including tables), should be in this file. Use rtf/doc files. Do not zip the files. Limit the file size to 1024 kb. Do not incorporate images in the file. The pages should be numbered consecutively, beginning with the first page of the blinded article file.

 

[3] Images: Submit good quality color images. Each image should be less than 4 MB in size. Size of the image can be reduced by decreasing the actual height and width of the images (keep up to 1800 × 1200 pixels or 5–6 inches). Images can be submitted as JPEG files. Do not zip the files. Legends for the figures/images should be included at the end of the article file.

 

[4] The contributors’/copyright transfer form (template provided below) must be submitted online from the author’s area on **** journals website link with the signatures of all the contributors within two weeks of submission. Alternatively, the authors can e-mail this form as a scanned image to jrs@gmail.com editor email address*